Hanne Lind

650 total citations
7 papers, 496 citations indexed

About

Hanne Lind is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Hanne Lind has authored 7 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Hanne Lind's work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Cells and Metastasis (2 papers). Hanne Lind is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Cells and Metastasis (2 papers). Hanne Lind collaborates with scholars based in United States. Hanne Lind's co-authors include Claudia Palena, Jeffrey Schlom, Caroline Jochéms, James L. Gulley, Sofia R. Gameiro, Renee N. Donahue, Julius Strauss, Nicole S. Spoelstra, Jennifer K. Richer and Melita A. Gordon and has published in prestigious journals such as Cancer Letters, Molecular Cancer Therapeutics and Cell Cycle.

In The Last Decade

Hanne Lind

7 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanne Lind United States	5	336	152	150	134	128	7	496
Zaoke He China	7	299 0.9×	150 1.0×	197 1.3×	202 1.5×	199 1.6×	8	545
Yuka Inoue Japan	14	353 1.1×	163 1.1×	234 1.6×	157 1.2×	86 0.7×	33	569
Rico D. Bense Netherlands	8	298 0.9×	153 1.0×	177 1.2×	141 1.1×	166 1.3×	9	508
Jolanta Szade Poland	12	266 0.8×	49 0.3×	143 1.0×	151 1.1×	78 0.6×	32	406
Akashi Ikubo Japan	9	180 0.5×	154 1.0×	180 1.2×	90 0.7×	54 0.4×	17	407
L Ryvo Israel	5	462 1.4×	167 1.1×	95 0.6×	140 1.0×	173 1.4×	8	544
Louqian Zhang China	11	147 0.4×	106 0.7×	149 1.0×	53 0.4×	139 1.1×	23	406
Zi-Hao Qi China	8	269 0.8×	135 0.9×	217 1.4×	168 1.3×	78 0.6×	9	523
Nina Seitzer United States	7	193 0.6×	98 0.6×	266 1.8×	76 0.6×	106 0.8×	9	431
Françoise Beltjens France	10	305 0.9×	129 0.8×	82 0.5×	161 1.2×	120 0.9×	32	469

Countries citing papers authored by Hanne Lind

Since Specialization

Citations

This map shows the geographic impact of Hanne Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanne Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanne Lind more than expected).

Fields of papers citing papers by Hanne Lind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanne Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanne Lind. The network helps show where Hanne Lind may publish in the future.

Co-authorship network of co-authors of Hanne Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Hanne Lind. A scholar is included among the top collaborators of Hanne Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanne Lind. Hanne Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lind, Hanne, Samantha M. Y. Chen, Sana D. Karam, et al.. (2024). MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-β in squamous cell carcinomas with enhanced CD8 T cell memory-driven response. Cancer Letters. 608. 217347–217347. 4 indexed citations

2.

Horn, Lucas A., Hanne Lind, Kristen Fousek, et al.. (2024). Inhibition of the chemokine receptors CXCR1 and CXCR2 synergizes with docetaxel for effective tumor control and remodeling of the immune microenvironment of HPV-negative head and neck cancer models. Journal of Experimental & Clinical Cancer Research. 43(1). 318–318. 4 indexed citations

3.

Williams, Michelle M., et al.. (2022). NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer. Cancers. 14(14). 3543–3543. 15 indexed citations

4.

Lind, Hanne, Sofia R. Gameiro, Caroline Jochéms, et al.. (2020). Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances. Journal for ImmunoTherapy of Cancer. 8(1). e000433–e000433. 201 indexed citations

5.

Horn, Lucas A., Kristen Fousek, Hanne Lind, et al.. (2020). Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity. Journal for ImmunoTherapy of Cancer. 8(1). e000326–e000326. 68 indexed citations

6.

Thomas, Alexandra, Hanne Lind, Angela Hong, et al.. (2017). Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells. Cell Cycle. 16(15). 1453–1464. 30 indexed citations

7.

Barton, Valerie N., Nicholas C. D’Amato, Melita A. Gordon, et al.. (2015). Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo. Molecular Cancer Therapeutics. 14(3). 769–778. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact